Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.

Sector

Healthcare

Industry

Biotechnology

CEO

Hatano, Kazuhiro

Employees

598

Website

www.linical.co.jp

IPO Date

2008-10-27

Headquarters

Shin-Osaka Brick Building, 10th Floor, 6-1 Miyahara 1-chome, Yodogawa-ku, Osaka 532-0003, Japan

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Linical 2183

Linical Earnings Call Summary

Linical Earnings

Transcripts

Events

About Linical Co., Ltd.

Linical
2183